Measurement of indocyanine green plasma disappearance rate by two different dosages

le Sakka, S, Koeck, H, Meier-Hellmann, A
Foilsithe 2004

Prognostic value of indocyanine green-plasma disappearance rate in critically ill patients

le Sakka, SG, Meier-Hellmann, A, Reinhart, K
Foilsithe 2002

Usefulness of intrathoracic blood volume in the early phase of hemodynamic instability of patients with sepsis or septic shock

le Sakka, SG, Meier-Hellmann, A, Reinhart, K
Foilsithe 1999

Assessment of intrathoracic blood volume and extravascular lung water by single transpulmonary thermodilution

le Sakka, SG, Meier-Hellmann, A, Reinhart, K
Foilsithe 1999

Procalcitonin — A new indicator of the systemic response to severe infections

le Karzai, W., Oberhoffer, M., Meier-Hellmann, A., Reinhart, K.
Foilsithe in Infection (1997)

Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream

le Samet, A., Śledzińska, A., Krawczyk, B., Hellmann, A., Nowicki, S., Kur, J., Nowicki, B.
Foilsithe 2013

A new questionnaire to determine the effect of team interaction in the ICU on perceived futility and intention to quit: results of a pilot study in two German hospitals

le Schwarzkopf, D, Bloos, F, Meier-Hellmann, A, Icke, C, Riedemann, N, Hartog, CS
Foilsithe 2014

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)

le Riess, H, Meier-Hellmann, A, Motsch, J, Elias, M, Kursten, F, Dempfle, C
Foilsithe 2007

Increased monocyte activation and tissue factor expression in patients with sepsis

le Dohrn, B, Russwurm, S, Vickers, J, Meier-Hellmann, A, Spangenberg, P, Lösche , W, Reinhart, K
Foilsithe 1998

Platelets and platelet-activating factor acetylhydrolase in septic patients

le Ruβwurm, S, Dohrn, B, Oberhoffer, M, Meier-Hellmann, A, Krause, S, Lösche, W, Reinhart, K
Foilsithe 1999

A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management

le VALENTINO, L A, MAMONOV, V, HELLMANN, A, QUON, D V, CHYBICKA, A, SCHROTH, P, PATRONE, L, WONG, W-Y
Foilsithe 2012

A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients

le Schädler, D, Porzelius, C, Jörres, A, Marx, G, Meier-Hellmann, A, Putensen, C, Quintel, M, Spies, C, Engel, C, Weiler, N, Kuhlmann, M
Foilsithe 2013

Clinical assessment of Optivate(®), a high‐purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

le DMOSZYNSKA, A., KULICZKOWSKI, K., HELLMANN, A., TRELINSKI, J., KLOCZKO, J., BAGLIN, T., HAY, C., O’SHAUGHNESSY, D., ZAWILSKA, K., MAKRIS, M., SHAIKH‐ZAIDI, R., GASCOIGNE, E., DASH, C.
Foilsithe in Haemophilia (2011)

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma

le Hus, I, Dmoszynska, A, Manko, J, Hus, M, Jawniak, D, Soroka-Wojtaszko, M, Hellmann, A, Ciepluch, H, Skotnicki, A, Wolska-Smolen, T, Sulek, K, Robak, T, Konopka, L, Kloczko, J
Foilsithe 2004

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

le Hochhaus, A, Masszi, T, Giles, F J, Radich, J P, Ross, D M, Gómez Casares, M T, Hellmann, A, Stentoft, J, Conneally, E, García-Gutiérrez, V, Gattermann, N, Wiktor-Jedrzejczak, W, le Coutre, P D, Martino, B, Saussele, S, Menssen, H D, Deng, W, Krunic, N, Bedoucha, V, Saglio, G
Foilsithe in Leukemia (2017)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

le Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Foilsithe in Leukemia (2016)

Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German I...

le Reinhart, K., Brunkhorst, F. M., Bone, H.-G., Bardutzky, J., Dempfle, C.-E., Forst, H., Gastmeier, P., Gerlach, H., Gründling, M., John, S., Kern, W., Kreymann, G., Krüger, W., Kujath, P., Marggraf, G., Martin, J., Mayer, K., Meier-Hellmann, A., Oppert, M., Putensen, C., Quintel, M., Ragaller, M., Rossaint, R., Seifert, H., Spies, C., Stüber, F., Weiler, N., Weimann, A., Werdan, K., Welte, T.
Foilsithe 2010

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

le Gratwohl, A, Pfirrmann, M, Zander, A, Kröger, N, Beelen, D, Novotny, J, Nerl, C, Scheid, C, Spiekermann, K, Mayer, J, Sayer, H G, Falge, C, Bunjes, D, Döhner, H, Ganser, A, Schmidt-Wolf, I, Schwerdtfeger, R, Baurmann, H, Kuse, R, Schmitz, N, Wehmeier, A, Th Fischer, J, Ho, A D, Wilhelm, M, Goebeler, M-E, Lindemann, H W, Bormann, M, Hertenstein, B, Schlimok, G, Baerlocher, G M, Aul, C, Pfreundschuh, M, Fabian, M, Staib, P, Edinger, M, Schatz, M, Fauser, A, Arnold, R, Kindler, T, Wulf, G, Rosselet, A, Hellmann, A, Schäfer, E, Prümmer, O, Schenk, M, Hasford, J, Heimpel, H, Hossfeld, D K, Kolb, H-J, Büsche, G, Haferlach, C, Schnittger, S, Müller, M C, Reiter, A, Berger, U, Saußele, S, Hochhaus, A, Hehlmann, R
Foilsithe in Leukemia (2016)